FDA and FTC warned NS Products that website claims make NaturaCure an unapproved infertility drug.
What happened
FDA reviewed www.naturacure.net in March 2021 and found the company takes orders there for NaturaCure; FTC reviewed the website in May 2021. The letter cites website claims and a customer testimonial saying NaturaCure can treat or cure infertility and related conditions such as endometriosis, uterine fibroids, PCOS, and blocked fallopian tubes. FDA says these claims establish the supplement is intended as a drug, but it is not FDA-approved and lacks adequate directions.
What FDA found
Website claims that NaturaCure cures, treats, or prevents infertility and other conditions make it a drug.
Section 201(g)(1)(B) of the Act [21 U.S.C. § 321(g)(1)(B)]NaturaCure is a new drug because it is not generally recognized as safe and effective for those uses and has no FDA approval.
Sections 201(p), 301(d), and 505(a) [21 U.S.C. §§ 321(p), 331(d), 355(a)]The product is misbranded because it lacks adequate directions for use; its intended diseases are not suitable for lay self-treatment.
Section 502(f)(1) [21 U.S.C. § 352(f)(1)]; 21 C.F.R. § 201.5Selling the misbranded drug in interstate commerce violates the Act.
Section 301(a) [21 U.S.C. § 331(a)]FTC says the advertising claims may lack competent and reliable scientific evidence.
FTC Act, 15 U.S.C. § 41 et seq.
What FDA wants
FDA asks NS Products to reply in writing within 15 working days with the specific steps taken to fix the violations, an explanation of how recurrence will be prevented, and related documents. If corrective actions cannot be completed in that time, the company must state why and when it will finish.
Who should pay attention
- dietary supplement companies making fertility claims
- online retailers and affiliate marketers of herbal supplements
- advertising reviewers handling testimonial-based health claims
This is a summary. Read the original letter on fda.gov.